-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Zentalis Pharmaceuticals, Maintains $10 Price Target

Benzinga·10/19/2026 10:31:04
HC Wainwright & Co. analyst Andres Y. Maldonado reiterates Zentalis Pharmaceuticals (NASDAQ:ZNTL) with a Buy and maintains $10 price target.